FWD does the one thing membership-model sellers almost never do: it publishes the member price and the non-member price side by side, so the cost of not joining is a number rather than a mystery. It also carries an FDA warning letter naming this exact domain.
What FWD charges
Sermorelin: $199.99/mo — the MEMBER monthly cell of the seller's own two-row grid, read as "Vial (3mg/ml) | Monthly | Quarterly | Member Price $199.99 $449.99 | Non-Members $299.99 $559.99" — ⛔ the non-member monthly rate is the higher figure in that same row and a reader who is not a member pays it; the quarterly cells are prepaid totals, not per-month rates, and were not divided. The page title rounds the member figure down by a cent
NAD+: $199.99/mo — the MEMBER monthly cell, read as "Vial (100mg/ml) | Monthly | Quarterly | Member Price $199.99 $399.99 | Non-Members $299.99 $499.99"; the non-member monthly rate is the higher figure in the same row and the quarterly cells are prepaid totals
NAD+: $149.99/mo — the MEMBER cell for the smaller of two sizes, read as "Vial (300mg/ml) | 15mL | 30ml | Member Price $149.99 $199.99 | Non-Members $249.99 $299.99" — ⛔ the two columns here are SIZES, not billing terms, unlike the injection page whose columns are Monthly and Quarterly; the seller reuses one grid for two different meanings and only the column headers say which
NAD+: $149.99/mo — the MEMBER monthly cell, read as "NAD+ Cream (10%) | Jar (10%, 30 g) | Monthly | Quarterly | Member Price $149.99 $299.99 | Non-Members $249.99 $399.99"; ⚠ the same page prints "40%+ Savings — Compare at $250+", a comparison to an unnamed third party and not a price of this seller's own
FWD is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
Two rows, one grid, no guessing
Every product page here carries the same grid. The strength runs along the top, the plan terms run across, and then two labelled rows give the member rate and the non-member rate for each column.
Most sellers on this market publish one figure and mention a membership somewhere else, leaving the reader to discover at checkout which of the two they are being charged. Here both are printed, in the same table, before anything is clicked.
This site records the member monthly cell, because it is the figure the page headline advertises, and writes the non-member rate into the qualifier so the row cannot be read as the only price.
The strengths are published too — a concentration and a container size beside each product — which is more product detail than most of this market gives at any price.
The same grid means two different things
On the injection pages the two columns are billing terms: monthly and quarterly. On the nasal page the two columns are container sizes. The layout is identical and only the column header distinguishes them.
A reader skimming from one page to the next, or a tool matching on position, will read a size as a term or a term as a size. The figures are all correct and the meaning of the grid changes underneath them.
This site records the column meaning explicitly on every row for that reason, and never divides a quarterly cell into a monthly one — a prepaid total is not a rate.
One page also advertises a percentage saving against a comparison figure that belongs to no named seller. That is a claim about somebody else's pricing and is not recorded as a price here.
A letter that names the domain
The regulator's live warning-letter index returns an exact match on this company's registered name, and the letter body names this site's own web address as the content reviewed.
That is the standard this record requires before attaching a letter to a seller: a match on the company-name column, then confirmation from the domain printed inside the letter itself. A full-text hit alone proves nothing.
The letter is recorded on the row with its reference number, its issue date and its address. Readers can go and read it.
On coverage the terms are candid in a way that works against the seller: certain services are available only in certain states, and a reader may not access the services from outside the states where its providers are licensed. No state is listed anywhere, so this record carries none.
Who it's for
Readers who want the membership discount shown as two numbers rather than described.
Buyers who want the concentration and container size printed beside the price.
Anyone comparing three delivery forms of one compound from a single seller.
Shoppers who want quarterly columns labelled as quarterly rather than smuggled in as rates.
Who should look elsewhere
Anyone who will not use a seller with an open regulatory letter against it.
Buyers who need to know which states are served before starting an intake.
Readers who need the dispensing pharmacy named.
Anyone who needs lab work inside the programme.
Strengths
Publishes a member rate and a non-member rate side by side, so the cost of not joining is visible before signup
Prints the strength of every product beside its price, which most of this roster leaves out entirely
Prices three separate delivery forms of one compound rather than a single headline product
Labels its quarterly columns as quarterly, so a prepaid total is not mistaken for a monthly rate
Trade-offs
Carries an FDA warning letter that names this company and this exact domain
Reuses one grid layout for two different meanings — billing terms on some pages, container sizes on others — with only the column header to tell them apart
The terms state that services are available only in certain states and no state is ever listed
No dispensing pharmacy is named — the answer is "our state-licensed compound pharmacies around the country"
One page advertises a percentage saving against an unnamed comparison price that is not this seller's own
The FAQ page footer carries a copyright year two years behind the about page on the same site
No lab work appears anywhere in the programme description
FDA disclosure
FWD received an FDA warning letter issued September 2025. A warning letter discloses; it does not, on its own, disqualify a provider — see the trade-offs above for what this one concerned.
How we verified this
Rendered every product page in a real browser and read only laid-out, visible text nodes.
Fired two nonsense paths at the host in the same session before the real pages; both returned an honest not-found response.
Compared the requested address against the arrived-at address on every fetch and confirmed they matched.
Read each grid's column headers before reading its cells, and recorded whether the columns were billing terms or container sizes on each page separately.
Recorded the page-title figure and the grid figure as the different numbers they are, rather than treating the rounded title as the price.
Queried the regulator's live warning-letter index, matched on the company-name column rather than a full-text hit, and confirmed the domain named inside the letter is this seller's own.
Ran a known-positive query and a nonsense query in the same regulator search session, so a rate-limited empty result could not be mistaken for a clean record.
Read the availability clause in the terms and recorded no coverage, because the terms name no state.
A provider to compare FWD against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.